“Does the dose of hydroxyurea correlate with shorter hospital stay and higher fetal hemoglobin levels in patients with sickle cell disease?”

Background & Aims Sickle cell disease (SCD) leads to recurrent vaso-occlusive crises (VOC) and hospitalizations, imposing a substantial healthcare burden. Hydroxyurea (HU) is known to reduce VOC frequency and hospitalization rates in SCD; however, data comparing the impact of different HU doses on l...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Musa Fares Alzahrani, Abdulaziz Albacker, Abdulmajeed Alshabanat, Maram Alharbi, Jawahir Abuhaimed, Nouran Arnous, Yara Alzahrani, Hind Aloraier, Maha Alamri, Rawan Altamimi, Ghazi Alotaibi, Sarah Sewaralthahab, Fatima Alshalti, Ibrahim Alrumaih, Ahmad Jamal, Farjah Algahtani, Aamer Aleem
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Taylor & Francis Group 2026-12-01
Σειρά:	Future Science OA
Θέματα:	Sickle cell disease sickle SCD hydroxyurea vaso-occlusive crisis
Διαθέσιμο Online:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2610223
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!